Reference on EC 3.5.1.109 - sphingomyelin deacylase
Please use the Reference Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Higuchi, K.; Hara, J.; Okamoto, R.; Kawashima, M.; Imokawa, G.
The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide
Biochem. J.
350
747-756
2000
Homo sapiens
Imokawa, G.
A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide
J. Dermatol. Sci.
55
1-9
2009
Homo sapiens
Hara, J.; Higuchi, K.; Okamoto, R.; Kawashima, M.; Imokawa, G.
High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis
J. Invest. Dermatol.
115
406-413
2000
Homo sapiens
Ishibashi, M.; Arikawa, J.; Okamoto, R.; Kawashima, M.; Takagi, Y.; Ohguchi, K.; Imokawa, G.
Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and the accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis
Lab. Invest.
83
397-408
2003
Homo sapiens
html completed